Matches in Wikidata for { <http://www.wikidata.org/entity/Q99081728> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q99081728 description "clinical trial" @default.
- Q99081728 description "ensayo clínico" @default.
- Q99081728 description "ensayu clínicu" @default.
- Q99081728 description "klinisch onderzoek" @default.
- Q99081728 description "клінічне випробування" @default.
- Q99081728 description "临床试验" @default.
- Q99081728 name "Azacitidine and Quizartinib for the Treatment of Myelodysplastic Syndrome or Myelodysplastic/Myeloproliferative Neoplasm With FLT3 or CBL Mutations" @default.
- Q99081728 name "Azacitidine and Quizartinib for the Treatment of Myelodysplastic Syndrome or Myelodysplastic/Myeloproliferative Neoplasm With FLT3 or CBL Mutations" @default.
- Q99081728 type Item @default.
- Q99081728 label "Azacitidine and Quizartinib for the Treatment of Myelodysplastic Syndrome or Myelodysplastic/Myeloproliferative Neoplasm With FLT3 or CBL Mutations" @default.
- Q99081728 label "Azacitidine and Quizartinib for the Treatment of Myelodysplastic Syndrome or Myelodysplastic/Myeloproliferative Neoplasm With FLT3 or CBL Mutations" @default.
- Q99081728 prefLabel "Azacitidine and Quizartinib for the Treatment of Myelodysplastic Syndrome or Myelodysplastic/Myeloproliferative Neoplasm With FLT3 or CBL Mutations" @default.
- Q99081728 prefLabel "Azacitidine and Quizartinib for the Treatment of Myelodysplastic Syndrome or Myelodysplastic/Myeloproliferative Neoplasm With FLT3 or CBL Mutations" @default.
- Q99081728 P1050 Q99081728-A764B741-2954-4EC9-AA66-B6685D91F62F @default.
- Q99081728 P1050 Q99081728-D1C41CC2-068E-4D4A-851D-EBD268430644 @default.
- Q99081728 P1050 Q99081728-DA677E55-B5AB-4220-B4F2-82C9629AB8D2 @default.
- Q99081728 P1132 Q99081728-A7D7D5CC-3EC9-4BBD-B8A6-9E8177F6117F @default.
- Q99081728 P1476 Q99081728-5864A0F4-C398-4573-9590-6491F81E941C @default.
- Q99081728 P17 Q99081728-68B082D7-AD43-4C0A-A260-5C99FF2D3BD9 @default.
- Q99081728 P2899 Q99081728-675AFF4A-C32B-4C8F-9563-0240CA2BCD67 @default.
- Q99081728 P3098 Q99081728-CE2348B7-3996-4B64-B6D3-900BE932EF3E @default.
- Q99081728 P31 Q99081728-0EC77069-15E9-4E4D-8677-C9C7C62724D6 @default.
- Q99081728 P4844 Q99081728-9CC3BF6A-F005-4A50-982B-BD6A1ABDB239 @default.
- Q99081728 P580 Q99081728-6FAFB46F-F4D1-4F1A-B579-28031A7B274E @default.
- Q99081728 P582 Q99081728-0973D907-6551-4A80-8A63-6E1717F19F62 @default.
- Q99081728 P6099 Q99081728-4764AE91-D251-47BD-A745-5847D84628D0 @default.
- Q99081728 P6099 Q99081728-6EA032C9-D085-455A-B3FF-324B1F772719 @default.
- Q99081728 P767 Q99081728-81C01901-A400-450D-B773-07E1CB638760 @default.
- Q99081728 P8005 Q99081728-2A148E0E-B168-4618-9BB4-85A3594F6673 @default.
- Q99081728 P8363 Q99081728-088B986C-2330-4AAD-9FA4-E0ABF6C684EB @default.
- Q99081728 P859 Q99081728-83829B34-C3B4-4D52-B8DD-053D4B10D89B @default.
- Q99081728 P1050 Q179630 @default.
- Q99081728 P1050 Q1898104 @default.
- Q99081728 P1050 Q29496 @default.
- Q99081728 P1132 "+58" @default.
- Q99081728 P1476 "Phase I/II Study of Azacitidine in Combination With Quizartinib for Patients With Myelodysplastic Syndromes and Myelodysplastic/Myeloproliferative Neoplasms With FLT3 or CBL Mutations" @default.
- Q99081728 P17 Q30 @default.
- Q99081728 P2899 "+18" @default.
- Q99081728 P3098 "NCT04493138" @default.
- Q99081728 P31 Q30612 @default.
- Q99081728 P4844 Q416451 @default.
- Q99081728 P580 "2020-07-21T00:00:00Z" @default.
- Q99081728 P582 "2022-02-03T00:00:00Z" @default.
- Q99081728 P6099 Q42824440 @default.
- Q99081728 P6099 Q5452194 @default.
- Q99081728 P767 Q664846 @default.
- Q99081728 P8005 Q76649708 @default.
- Q99081728 P8363 Q78089383 @default.
- Q99081728 P859 Q1525831 @default.